Abstract:Background: To improve the treatment of painful Diabetic Peripheral Neuropathy (DPN) and associated co-morbidities, a better understanding of the pathophysiology and risk factors for painful DPN is required. Using harmonised cohorts (N = 1230) we have built models that classify painful versus painless DPN using quality of life (EQ5D), lifestyle (smoking, alcohol consumption), demographics (age, gender), personality and psychology traits (anxiety, depression, personality traits), biochemical (HbA1c) and clinical variables (BMI, hospital stay and trauma at young age) as predictors. Methods: The Random Forest, Adaptive Regression Splines and Naive Bayes machine learning models were trained for classifying painful/painless DPN. Their performance was estimated using cross-validation in large cross-sectional cohorts (N = 935) and externally validated in a large population-based cohort (N = 295). Variables were ranked for importance using model specific metrics and marginal effects of predictors were aggregated and assessed at the global level. Model selection was carried out using the Mathews Correlation Coefficient (MCC) and model performance was quantified in the validation set using MCC, the area under the precision/recall curve (AUPRC) and accuracy. Results: Random Forest (MCC = 0.28, AUPRC = 0.76) and Adaptive Regression Splines (MCC = 0.29, AUPRC = 0.77) were the best performing models and showed the smallest reduction in performance between the training and validation dataset. EQ5D index, the 10-item personality dimensions, HbA1c, Depression and Anxiety t-scores, age and Body Mass Index were consistently amongst the most powerful predictors in classifying painful vs painless DPN. Conclusions: Machine learning models trained on large cross-sectional cohorts were able to accurately classify painful or painless DPN on an independent population-based dataset. Painful DPN is associated with more depression, anxiety and certain personality traits. It is also associated with poorer self-reported quality of life, younger age, poor glucose control and high Body Mass Index (BMI). The models showed good performance in realistic conditions in the presence of missing values and noisy datasets. These models can be used either in the clinical context to assist patient stratification based on the risk of painful DPN or return broad risk categories based on user input. Model's performance and calibration suggest that in both cases they could potentially improve diagnosis and outcomes by changing modifiable factors like BMI and HbA1c control and institute earlier preventive or supportive measures like psychological interventions.

Measuring Pain in Sickle Cell Disease using Clinical Text

AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain

Hybrid Statistical and Mechanistic Mathematical Model Guides Mobile Health Intervention for Chronic Pain

Pain Forecasting using Self-supervised Learning and Patient Phenotyping: An attempt to prevent Opioid Addiction

Exploring machine learning algorithms in sickle cell disease patient data: A systematic review

AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain

Use of consumer wearables to monitor and predict pain in patients with sickle cell disease

Can we use biomarkers to identify those at risk of acute pain from sickle cell disease?

Identifying Mentions of Pain in Mental Health Records Text: A Natural Language Processing Approach

PainMeter: Automatic Assessment of Pain Intensity Levels From Multiple Physiological Signals Using Machine Learning

Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease

Differential clinical characteristics across traditional Chinese medicine (TCM) Syndromes in patients with sickle cell disease

Machine learning clinical decision support for interdisciplinary multimodal chronic musculoskeletal pain treatment

Computing Sickle Erythrocyte Health Index Based on Quantitative Phase Imaging and Machine Learning

Pain screening in youth with sickle cell disease: A quality improvement study

A Scoping Review of Social Determinants of Health and Pain Outcomes in Sickle Cell Disease

What is the future of digital tools to help manage pain in sickle cell disease patients?

Predicting Chronic Pain and Treatment Outcomes Using Machine Learning Models Based on High-Dimensional Clinical Data From a Large Retrospective Cohort

Classification of painful or painless diabetic peripheral neuropathy and identification of the most powerful predictors using machine learning models in large cross-sectional cohorts

Data – Knowledge driven machine learning model for cancer pain medication decisions

The impact of a single music therapy session on pain perception of patients with sickle cell disease